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CC BY-NC-ND license (http://creativAbstract Lupus erythematosus panniculitis (LEP) is an uncommon variant of LE and accounts
for only 1e3% of cutaneous LE cases. LEP lesions often heal with cutaneous scarring and lipoa-
trophy resulting in disfigurement. Studies regarding the treatment of permanent lipoatrophy
and disfigurement caused by LEP are lacking in the literature. Here, we report our experience
with a rare case of lipoatrophy caused by LEP that was treated using autologous fat grafting. A
41-year-old woman presented with indurated, flesh-colored, depressed plaques on both but-
tocks. After a series of investigations, LEP was diagnosed by a rheumatologist. Magnetic reso-
nance imaging (MRI) showed a markedly decreased volume of the subcutaneous fatty layer and
thickening over the covering cutis. After the inflammatory disease was controlled, we at-
tempted to restore her body contour with autologous fat grafting. We arranged an MRI study
after a follow-up period of 12 months. The volume of subcutaneous fat was calculated by inte-
grating cross-sectional area data from consecutive images. The patient was satisfied with her
body contour following the injection of 350 mL of fat into the right buttock and 50 mL into the
left buttock in a two-stage procedure. No complications were observed following the proce-
dure. Follow-up laboratory results were negative for anti-double-stranded DNA antibody and
showed normal complement levels. After a follow-up period of 12 months, no nodules or dis-
ease reactivation was noted. The MRI showed a marked improvement in the volume of the sub-
cutaneous fat of the buttock, and the survival ratio of transferred fat was calculated to be 65%.
Lipoatrophy secondary to LEP is a rare disease that can cause distress to patients. Autologous
fat grafting is a simple, fast, and effective method for alleviating depression deformities ind.
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28 H.-P. Huang et al.patients with LEP. It has a potentially long-lasting effect in treating patients with permanent
lipoatrophy and disfigurement caused by LEP but should be preferably performed only in pa-
tients with quiescent disease.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Figure 1 Indurated, flesh-colored, depressed plaque with
more severe depression on the right buttock in our patient.1. Introduction
Lupus erythematosus panniculitis (LEP) is an uncommon
variant of LE and accounts for only 1e3% of cutaneous LE
cases.1e3 LEP is clinically characterized by erythematous or
flesh-colored deep nodules in an inflammatory phase and
generally occurs on the face, arms, legs, trunk, and
abdominal regions. Although various medical treatments
have been used for treating LEP,4 disfigurement is
frequently observed because of lipoatrophy.
Few reports regarding the treatment of permanent lip-
oatrophy and disfigurement caused by LEP currently exist in
literature. Eastham et al5 used hyaluronic acid and poly-L-
lactic acid for soft tissue augmentation in cases of exten-
sive LEP-induced facial atrophy. However, the effect was
nonpermanent, and the material used in the augmentation
was suspected to cause the reactivation of connective tis-
sue disease.
The fat grafting technique is currently applied for both
cosmetic and reconstructive purposes. The procedure is
used for breast reconstruction, facial rejuvenation, body
contouring, and correction of posttraumatic and post-
surgical deformities.6 However, data regarding fat grafting
in LEP are limited. Valdatta et al7 injected autologous fat
into a patient with LEP with facial lipoatrophy in a three-
stage procedure and reported satisfactory results during a
follow-up period of 12 months. Gleeson et al8 treated facial
lipoatrophy in three patients with LEP by using fat grafting
but reported that one of the patients experienced an acute
fatal fat embolism following the procedure.
Here, we report our experience regarding a rare case of
lipoatrophy caused by LEP treated using fat grafting.Figure 2 Magnetic resonance imaging showing significantly
decreased volume of the subcutaneous fatty layer and thick-
ening of the covering cutis.2. Case report
A 41-year-old woman with a 6-month history of a depression
over both buttocks caused by LEP was referred for treat-
ment. Cutaneous examination revealed indurated, flesh-
colored, depressed plaques with a severe hollow appear-
ance of the right buttock (Figure 1). Magnetic resonance
imaging (MRI) showed a markedly decreased volume of the
subcutaneous fatty layer and thickening of the covering
cutis (Figure 2). Physical examination and laboratory tests
revealed arthritis, malar rash, oral ulcer, antineutrophil
antibody (1:160, nucleolar pattern), and anti-double-
stranded DNA antibody positivity (14.3 IU/mL; normal
range, 0.0e10.0 IU/mL). A rheumatologist diagnosed LEP
according to the 1997 revised criteria for classifying sys-
temic LE. Inflammatory disease was controlled for 3 months
by using a combination of sulfasalazine, prednisolone, andazathioprine. The patient requested restoration of body
contour.
She underwent autologous fat grafting using the Cole-
man technique. In the first grafting attempt, we harvested
subcutaneous fat from both lateral thighs by using aspira-
tion cannulas 2 mm in diameter. The aspirated fluid was
centrifuged at 604g (CN-820 simple type centrifuge,
Hsiangtai Machinery Industry Co. Ltd., Taiwan) for 2 mi-
nutes. The fat tissue was then transferred to a 3-cm3 Luer
lock syringe (Terumo Syringe 5 cc; Medical Co.,Tokyo,
Japan) for injection. We injected 200 mL of fat into the
depressed area of the right buttock and 20 mL into the left
buttock to correct the deformity. Six months later, the
lesion showed marked improvement, particularly on the
Figure 3 Six months after two fat grafting procedures.
Lupus erythematosus panniculitis 29right buttock. However, because a depressed body contour
was still noted, she asked for a repeat procedure. We
harvested fat from the bilateral flank and injected 150 mL
into the right buttock and 30 mL into the left buttock. We
arranged an MRI study after a follow-up period of 12
months. The volume of subcutaneous fat was calculated by
integrating cross-sectional area data from consecutive
images.
The patient was satisfied with her body contour after the
injection of 350 mL of fat into the right buttock and 50 mL
into the left buttock in a two-stage procedure. No compli-
cations were observed following the procedure. Follow-up
laboratory examination results were negative for anti-
double-stranded DNA antibody and showed normal com-
plement levels. After a follow-up period of 6 months, no
nodules or disease reactivation was noted (Figure 3). A
significant improvement in the volume of the subcutaneous
fat of the buttock was noted in the MRI taken 12 months
after surgery (Figure 4), and the survival ratio of trans-
ferred fat was 65% by calculation.
3. Discussion
Compared with other LE forms, LEP is more frequent in
women. The average age of onset (from late 30s to earlyFigure 4 A distinct improvement is shown on magnetic reso-
nance imaging 12 months after surgery. The volume of subcu-
taneous fat in the buttock has increased markedly.40s) of LEP is similar to that of other chronic cutaneous LE
forms. LEP has a chronic relapsing clinical course. Patients
develop tender subcutaneous nodules or plaques, most
commonly on the proximal extremities (face, shoulders,
upper arms, breasts, hips, and buttocks) but rarely on the
distal extremities.9 Following the nodular stage, these in-
flammatory lesions often heal with cutaneous scarring and
lipoatrophy that lead to disfigurement. Chronic inflamma-
tion and hyaline necrosis of the subcutaneous tissue can be
seen histologically.10 An autoimmune etiology is confirmed
by the presence of antinuclear antibodies and low com-
plement levels. LEP with changes consistent with those in
discoid LE is sometimes referred to as lupus profundus.11
Other possible complications include alopecia, enoph-
thalmos, central retinal artery occlusion, mastitis, throm-
bophlebitis, and proptosis.12 Despite its benign
characteristics, lipoatrophy can affect body shape and
appearance, thus affecting the psychological aspect in
daily life.
Dermal fillers have been used for treating disfigurement
caused by LEP,5 but neither permanent nor nonpermanent
fillers have shown promising results.13 Problems exist
regarding the use of dermal fillers in patients with con-
nective tissue disease. Because of the theoretical risk of
the reactivation of connective tissue disease as a result of
antigenic stimulation,14 complications such as granuloma-
tous “rubberizing” reaction can occur, but are rare.15
Here we report on a patient with LPE who underwent a
staged fat grafting procedure with a 35% loss of transferred
fat after 12 months. Fat grafting to treat three-dimensional
defects of lipoatrophy has the following advantages: a
simple surgical procedure, shorter convalescence period,
readily available source, and potentially long-lasting ef-
fect. However, a study including 10 participants reported a
50% loss of transferred fat within 3 months of the proce-
dure, with an additional 6% loss noted between 3 months
and 6 months after the procedure; no fat loss was reported
thereafter.16 Therefore, a staged fat grafting procedure
may be required to achieve the target volume.
Complications of fat grafting, such as infection, bruising,
and hematoma or seroma formation, are rare. Similarly, the
risk of fat embolism is believed to be low, and the incidence
of fat embolism for large abdominal liposuctions is esti-
mated to be 1.3 per 100,000 population.17,18 Liposuction
with tumescent anesthesia and fat reinjection are generally
regarded as safe. However, Gleeson et al8 described a pa-
tient with LEP who died as a result of fulminant fat tissue
embolism after the grafting of a small volume (35 mL) of
autologous fat for facial lipoatrophy. It appears that in
cases with substantial lipoatrophy and subcutaneous scar-
ring because of LEP, fat injection into the surrounding
fibrotic tissue can facilitate the entry of fat into the venous
circulation. Furthermore, because LEP is an inflammatory
disease, the risk of inflammatory reaction is higher when
fat and vascular endothelium come in contact. Whether fat
grafting for patients with LEP is related to a higher risk of
fat embolism syndrome requires in-depth study.
Although fat embolism is a rare complication of the fat
grafting technique, it is the most severe and lethal. To
avoid fat embolism syndrome, using a large, blunt cannula
rather than a small, sharp cannula can prevent the perfo-
ration of the vascular wall, thus avoiding entry of fat into
30 H.-P. Huang et al.the venous circulation. Epinephrine at the injection site
induces vasoconstriction, thus making it more difficult to
cannulate the vessel.19 In addition, the surgeon should
ensure that only minimal force is exerted. Aspiration should
be performed before fat is injected to avoid contact with
veins and arteries.20
Treatment for sequelae of panniculitis, including surgi-
cal techniques and filler injections, remains controversial in
the active inflammatory phase of the disease because
trauma itself may be an inciting factor; the lesions have a
chronic, remitting course that can be exacerbated by
trauma.9 Corrective techniques may be considered for
stable, noninflammatory atrophic plaques. However, con-
trolling the disease before initiation of such treatments is
crucial.4
In conclusion, lipoatrophy secondary to LEP is a rare but
potentially disfiguring disease that can cause distress to pa-
tients. Autologous fat grafting is a simple, fast, and effective
procedure for alleviating depression deformities. It has a
potentially long-lasting effect in treating permanent lipoa-
trophy and disfigurement caused by LEP but should be per-
formed only in patients with quiescent disease.
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